Volume : 09, Issue : 11, November – 2022
Title:
44.NURSING RULES PULMONARY REHABILITATION FOR COPD PATIENT
Authors :
Naif Sueid Alotibi,Dareen Essam Ghalman,Ahmed Shabib Al-Maqati,Mansour Ateyan Alharbi,Aisha barakah Albeladi,Jameel Wasl Allah Albeshri,Talal Saeed Alghamdi,Mohammed Saeed Alghamdi,Abdullah Mohammed Bareq Alqarni Alsuhaymi
Abstract :
Literature search till the beginning of 2022 for all relevant studies publish in English language among different databases such as; PubMed and Embase. Many physical, emotional, and social symptoms may be present in COPD patients, necessitating a comprehensive, targeted intervention in the form of a personalized pulmonary rehabilitation (PR) program. Taking into account the disease’s complexity and severity, good PR must incorporate the translation of information and evidence of recognized aspects into a multidimensional, complex intervention. In this manner, PR will increase the patient’s individual autonomy and maximize the patient’s autonomy and community functioning. PR is defined as a comprehensive strategy designed to sustainably enhance physical, psychological, and social outcomes in individuals with chronic respiratory problems. PR is a personalized, sophisticated health care intervention. Although exercise training has been recognized as the cornerstone of a comprehensive PR program, a profound pathophysiology understanding of the mechanisms governing exercise tolerance, particularly in COPD patients, necessitates the consideration of several training modalities.
Cite This Article:
Please cite this article in press Naif Sueid Alotibi et al, Nursing Rules Pulmonary Rehabilitation For COPD Patient., Indo Am. J. P. Sci, 2022; 09(11)..
Number of Downloads : 10
References:
2. Pulmonary rehabilitation-1999. American Thoracic Society. Am J Respir Crit Care Med 1999;159:1666–82.
3. Rochester CL. Exercise training in chronic obstructive pulmonary disease. J Rehabil Res Dev 2003;40:59–80.
4. Donner CF, Muir JF. Selection criteria and programmes for pulmonary rehabilitation in COPD patients. Rehabilitation and Chronic Care Scientific Group of the European Respiratory Society. Eur Respir J 1997;10:744–57.
5. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA 2002;288:2469–75.
6. Jones SW, Hill RJ, Krasney PA, O’Conner B, Peirce N, Greenhaff PL. Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass. FASEB J 2004;18:1025–7.
7. Faager G, Larsen FF. Performance changes for patients with chronic obstructive pulmonary disease on long-term oxygen therapy after physiotherapy. Journal of Rehabilitation Medicine 2004;36(4):153–8
8. Chlumsky J, Sterbova L, Smolikova L, Matous M, Salajka F. The effect of pulmonary rehabilitation on exercise tolerance and quality of life in patients with COPD. Preliminary data. European Respiratory Journal 2001;18(Suppl):223S.
9. Nalbant O, Nur H, Ogus C, Toraman NF. Effects of long-term aerobic exercise program in chronic obstructive pulmonary disease. Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi 2011;57(1):8–13.
10. Ozdemir EP, Solak O, Fidan F, Demirdal US, Evcik, D, Unlu M, et al. The effect of water-based pulmonary rehabilitation on anxiety and quality of life in chronic pulmonary obstructive disease patients. Turkiye Klinikleri Journal of Medical Sciences 2010;30(1):880–7
11. Akinci AC, Olgun N. The effectiveness of nurse-led, homebased pulmonary rehabilitation in patients with COPD in Turkey. Rehabilitation Nursing 2011;36(4):159–65.
12. O’Donnell DE, Laveneziana P, Webb K, et al. Chronic obstructive pulmonary disease: clinical integrative physiology. Clin Chest Med. 2014;35(1):51–69.
13. Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014;9:871–888.
14. Choudhury G, Rabinovich R, MacNee W. Comorbidities and systemic effects of chronic obstructive pulmonary disease. Clin Chest Med. 2014;35(1):101–130.
15. Guder G, Rutten FH. Comorbidity of heart failure and chronic obstructive pulmonary disease: more than coincidence. Curr Heart Fail Rep. 2014;11(3):337–346.
16. Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155–161.
17. American Thoracic Society/European Respiratory S. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166(4):518–624.
18. Neder JA, Arbex FF, Alencar MC, et al. Exercise ventilatory inefficiency in mild to end-stage COPD. Eur Respir J. 2015;45(2):377–387.
19. Foster S, Thomas III HM. Pulmonary rehabilitation in lung disease other than chronic obstructive pulmonary disease. Am Rev Respir Dis 1990;141:601–4.
20. Congleton J, Bott J, Hindell A, duBois RM, Simonds AK. Comparison of outcome of pulmonary rehabilitation in obstructive lung disease, interstitial lung disease and chest wall disease. Thorax 1997;52(Suppl. 6):A11.
21. Ware JJ, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473–83.
22. American Association of Cardiovascular and Pulmonary Rehabilitation. Guidelines for pulmonary rehabilitation programs, 3rd ed. Champaign, IL: Human Kinetics; 2004.
23. Puhan MA, Gimeno-Santos E, Cates CJ, et al. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2016;12:CD005305.
24. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013;188:e13-64.
25. Bolton CE, Bevan-Smith EF, Blakey JD, et al. British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax 2013;68 Suppl 2:ii1-30.
26. Greening NJ, Williams JE, Hussain SF, et al. An early rehabilitation intervention to enhance recovery during hospital admission for an exacerbation of chronic respiratory disease: randomised controlled trial. BMJ 2014;349:4315.